Skip Navigation LinksHome > Editorial Board

Editorial Board

Editors
David A. Cooper
University of New South Wales,
Sydney, Australia
Giuseppe Pantaleo
University of Lausanne
Lausanne, Switzerland

Editorial Board
Marcus Altfeld
University of Hamburg,
Hamburg, Germany

Susan Buchbinder
San Francisco Department of Public Health,
San Francisco, USA

Steven Deeks
University of California,
San Francisco, USA

S Fidler
Imperial College London,
London, UK

Geoff Garnett
Bill & Melinda Gates Foundation,
Seattle, USA

Barton F. Haynes
Duke University Medical Center,
Durham, USA

John Kaldor
University of New South Wales,
Sydney, Australia

Christine Katlama
Pitie-Salpetriere Hospital,
Paris, France

Richard A. Koup
National Institutes of Health,
Bethesda, USA

Michael M. Lederman
Case Western Reserve University,
Cleveland, USA

Joseph M. McCune
University of California,
San Francisco, USA

M. Juliana McElrath
University of Washington,
School of Medicine,
Seattle, USA

David C. Montefiori
Duke University Medical Center,
Durham, USA

Praphan Phanuphak
Thai Red Cross Society,
Bangkok, Thailand

Peter Reiss
National AIDS Therapy Evaluation Center,
Amsterdam, The Netherlands

Douglas D. Richman
University of California San Diego,
San Diego, USA

Jurgen K. Rockstroh
University Hospital Bonn,
Bonn, Germany

N Russell
Bill & Melinda Gates Foundation,
Seattle, USA

C Sabin
University College London,
London, UK

RF Siliciano
Johns Hopkins University School of Medicine,
Baltimore, USA

G Silvestri
Emory University School of Medicine,
Atlanta, USA

GD Tomaras
Duke University Medical Center,
Durham, USA

Mark Wainberg
McGill University,
Montreal, Canada


Sections

January
The PrEP revolution; from clinical trials to routine practice
Edited by Jared Baeten,
University of Washington,
Pennsylvania, USA
and Sheena McCormack,
MRC Clinical Trials Unit, London, UK

March
Immune Activation

Edited by Immune Activation,
National Institutes of Health, Maryland, USA  
and Marcus Altfeld, the Heinrich-Pette-Institute (HPI)

May
Bone complications in HIV

Edited by Patrick Mallon,
University College Dublin, Ireland
and Todd Brown, Johns Hopkins University,Maryland, USA

July
Strategies for targeting residual HIV infection
Edited by Nicolas Chomont,
Université de Montréal – CHUM Research Center,
Canada and Matthieu Perreau,
Lausanne University Hospital, Lausanne, Switzerland

September
Survival in the modern ART era
Edited by Margaret May,
University of Bristol and Dominique Costagliola,
Institut national de la santé et de la recherche médicale (INSERM), France

November
HIV Vaccine
Edited by Jerome Kim , International Vaccine Institute, USA and Stephen Kent University of Melbourne, Australia